Advertisement
Research Article

Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN

  • Yanyuan Wu equal contributor,

    equal contributor Contributed equally to this work with: Yanyuan Wu, Marianna Sarkissyan

    Affiliations: Division of Cancer Research and Training, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Department of Internal Medicine, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Charles R. Drew University of Medicine and Science, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center and David Geffen UCLA School of Medicine, Los Angeles, California, United States of America

    X
  • Marianna Sarkissyan equal contributor,

    equal contributor Contributed equally to this work with: Yanyuan Wu, Marianna Sarkissyan

    Affiliations: Division of Cancer Research and Training, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Department of Internal Medicine, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Charles R. Drew University of Medicine and Science, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America

    X
  • Yahya Elshimali,

    Affiliations: Division of Cancer Research and Training, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Department of Internal Medicine, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Charles R. Drew University of Medicine and Science, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America

    X
  • Jaydutt V. Vadgama mail

    jayvadgama@cdrewu.edu

    Affiliations: Division of Cancer Research and Training, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Department of Internal Medicine, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Charles R. Drew University of Medicine and Science, David Geffen UCLA School of Medicine, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center and David Geffen UCLA School of Medicine, Los Angeles, California, United States of America

    X
  • Published: October 22, 2013
  • DOI: 10.1371/journal.pone.0078259

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.